Cas 1267362-25-3,ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate

1267362-25-3

Post Buying Request

Basic information

Product Name: ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate
Synonyms: ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate
CAS NO:1267362-25-3
Molecular Formula:
Molecular Weight: 271.111
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate(CAS DataBase Reference)
NIST Chemistry Reference: ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate(1267362-25-3)
EPA Substance Registry System: ethyl (E)-3-(2-bromo-6-hydroxyphenyl)prop-2-enoate(1267362-25-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1267362-25-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1267362-25-3 Suppliers

Recommended suppliers

1267362-25-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1267362-25-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,7,3,6 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1267362-25:
(9*1)+(8*2)+(7*6)+(6*7)+(5*3)+(4*6)+(3*2)+(2*2)+(1*5)=163
163 % 10 = 3
So 1267362-25-3 is a valid CAS Registry Number.

1267362-25-3Upstream product

1267362-25-3Downstream Products

319478-14-3 5-bromochromane

1267362-25-3Relevant academic research and scientific papers

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

-

Paragraph 0303-0304, (2020/11/03)

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATING CANCER

-

Paragraph 0218-0219, (2020/12/29)

Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.

PRC2 INHIBITORS

-

Paragraph 0203-0205, (2019/08/26)

The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. (Formula (I))

One-pot synthesis of α,β-unsaturated esters promoted by sodium hydride

Swetha,Venkata Ramana,Shirodkar

experimental part, p. 522 - 524 (2011/12/15)

A new protocol for the synthesis of α,β-unsaturated esters was described with various aldehydes and ethyl acetate in presence of sodium hydride. Advantage of this method is high efficiency, shorter time period and inexpensive.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1267362-25-3